GB0809068D0 - The use of serine protease inhibitors - Google Patents
The use of serine protease inhibitorsInfo
- Publication number
- GB0809068D0 GB0809068D0 GBGB0809068.0A GB0809068A GB0809068D0 GB 0809068 D0 GB0809068 D0 GB 0809068D0 GB 0809068 A GB0809068 A GB 0809068A GB 0809068 D0 GB0809068 D0 GB 0809068D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- protease inhibitors
- serine protease
- serine
- inhibitors
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003001 serine protease inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0709494A GB0709494D0 (en) | 2007-05-17 | 2007-05-17 | Therapeutic use |
GB0800489A GB0800489D0 (en) | 2008-01-11 | 2008-01-11 | Therapeutic use |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0809068D0 true GB0809068D0 (en) | 2008-06-25 |
GB2450780A GB2450780A (en) | 2009-01-07 |
Family
ID=39596132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0809068A Withdrawn GB2450780A (en) | 2007-05-17 | 2008-05-19 | Compositions containing serine protease inhibitors |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2450780A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011338199A1 (en) * | 2010-12-10 | 2013-05-23 | Skinvisible Pharmaceuticals, Inc. | Compositions for treating dermatitis and ichthyosis, and methods for treating dermatitis and ichthyosis |
WO2024159008A1 (en) * | 2023-01-25 | 2024-08-02 | Quoin Pharmaceuticals, Inc. | Combination treatment for netherton syndrome |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4978534A (en) * | 1987-12-12 | 1990-12-18 | Kazuo Saitoh | Gabexate mesylate ointment |
JPH06192085A (en) * | 1992-08-31 | 1994-07-12 | Yuji Inada | Therapeutic agent for mite allergy |
US5346886A (en) * | 1993-11-15 | 1994-09-13 | John Lezdey | Topical α-1-antitrypsin, non-aqueous lipid miscible, benzalkonium chloride compositions for treating skin |
WO2005117955A1 (en) * | 2004-05-19 | 2005-12-15 | Arriva Pharmaceuticals, Inc. | Treatment of atopic dermatitis with unglycosylated alpha one-antitrypsin |
-
2008
- 2008-05-19 GB GB0809068A patent/GB2450780A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2450780A (en) | 2009-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL200611A0 (en) | Inhibitors of serine proteases | |
LTC2178888I2 (en) | Protease inhibitors | |
HK1144198A1 (en) | Macrocyclic serine protease inhibitors | |
IL189668A0 (en) | Inhibitors of serine proteases | |
IL189192A0 (en) | Inhibitors of serine proteases | |
EP2148693A4 (en) | Alpha-i antitrypsin having no significant serine protease inhibitor activity | |
EP2224801A4 (en) | Macrocyclic oximyl hepatitis c serine protease inhibitors | |
EP2139883A4 (en) | Hiv-1 protease inhibitors | |
ZA200902091B (en) | Serine hydrolase inhibitors | |
EP2064177A4 (en) | Protease inhibitors | |
EP2313426A4 (en) | Novel protease inhibitors | |
EP2134336A4 (en) | Benzofuran-derived hiv protease inhibitors | |
ZA201102179B (en) | Protease inhibitors | |
GB0809068D0 (en) | The use of serine protease inhibitors | |
HK1140480A1 (en) | Cysteine protease inhibitors | |
GB0817425D0 (en) | Protease inhibitors | |
EP2139876A4 (en) | Cathepsin cysteine protease inhibitors | |
GB0705212D0 (en) | Protease inhibitors | |
GB0700378D0 (en) | Protease inhibitors | |
GB0712543D0 (en) | Protease inhibitors | |
GB0705213D0 (en) | Protease inhibitors | |
GB0712176D0 (en) | Protease inhibitors | |
GB0712544D0 (en) | Protease inhibitors | |
GB0700369D0 (en) | Protease inhibitors | |
IL175280A0 (en) | Retroviral protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |